Hearing Loss, Central: Clinical Trials

3 trials for Hearing Loss, Central, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting, 1 unknown. 1 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable1Recruiting 1

Follow Hearing Loss, Central: new trials by email Literature Review of Hearing Loss, Central trials Research Report on Hearing Loss, Central

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparing Hearing Aid Fitting Methods in Blast-exposed Veterans
Phonak Lumina P90 - Auditory Diseases, Central
Not applicableRecruitingVA Office of Research and Development802024-04-012026-04-14
The Contributions of Age Related Changes in the Sound Localization Pathway to Central Hearing Loss
Audiological Assessments - Healthy Individuals, Hearing Loss, Central
UnknownUniversity of Colorado, Denver2002020-10-012023-08-15
Neural Changes in the Aging Auditory System
Hormone Replacement Therapy - HRT - Progesterone, Estrogens
CompletedUniversity of Rochester1262001-01-012005-12-12

Narrower conditions

Auditory Perceptual Disorders (2)  ·  Auditory Diseases, Central (1)  ·  Blast Injuries (1)  ·  Hearing Disorders (1)  ·  Hearing Loss (1)  ·  Hearing Loss, Bilateral (1)  ·  Hearing Loss, Hidden (1)  ·  Hearing Loss, Sensorineural (1)  ·  Presbycusis (1)

Broader conditions

Brain Diseases (3)  ·  Central Nervous System Diseases (3)  ·  Ear Diseases (3)  ·  Nervous System Diseases (3)  ·  Neurologic Manifestations (3)  ·  Otorhinolaryngologic Diseases (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Retrocochlear Diseases (3)  ·  Sensation Disorders (3)  ·  Signs and Symptoms (3)  ·  Auditory Diseases, Central (2)  ·  Cognition Disorders (2)  ·  Hearing Disorders (2)  ·  Hearing Loss (2)  ·  Hearing Loss, Sensorineural (2)

Interventions

Hormone Replacement Therapy (1)

Sponsors

University of Colorado, Denver (1)  ·  University of Rochester (1)  ·  VA Office of Research and Development (1)

Countries

United States (3)

Top investigators

Daniel Tollin, PhD (1)  ·  Jonathan Venezia, PhD (1)  ·  Robert D Frisina, Ph.D. (1)

NIH funding

I01RX005059 (1), P01AG009524 (1), R01DC017924 (1)